Clinical trial
Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH
NCT02652429
Study timeline
Study start (actual)2016-03-01Date precision: month
Registry last updated2023-02-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Pulmonary Arterial Hypertensionunresolved
Interventions
Sponsors & collaborators
Bellerophon Pulse Technologieslead sponsor
Mapped research locations
New YorkNew York, United States1Los AngelesCalifornia, United States1DallasTexas, United States1BaltimoreMaryland, United States1TorontoOntario, Canada1ClevelandOhio, United States1PittsburghPennsylvania, United States1BirminghamAlabama, United States1CincinnatiOhio, United States1ColumbusOhio, United States1DurhamNorth Carolina, United States1AuroraColorado, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02652429 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.